Hansoh (3692.HK) vs Innovent (1801.HK) stock: side by side
How do Hansoh and Innovent stocks compare?
Hansoh vs Innovent in our two reports
Revenue growth2025
22.6 %
38.4 %
Price per dollar of profit: different dates, no mark
P/E, last 12 monthsat each report's price
24.6x
111.6x
P/E, next 12 monthsat each report's price
23.6x
35.0x
New accounts get one company's ready report free. No card.New accounts get one company's ready report free. No card.
= ahead, marked only when both figures cover the same kind of period. Not a buy or sell call.
Is Hansoh or Innovent the better stock?
Our reports do not pick one: neither makes a buy or sell call. Each names what its company's case needs to go right.
Hansoh discovers, makes and sells prescription medicines, led by cancer drugs, for patients through hospitals and pharmacies.
Innovent develops, makes and sells prescription medicines, mainly in China, for cancer, weight management, cholesterol, eye and immune diseases.
Which grows faster, Hansoh or Innovent?
Each figure as its report prints it, with its own period; a mark only where both cover the same kind of period.
Revenue growth
- Hansoh22.6 %
- Innovent38.4 %
Hansoh: 2025. Innovent: 2025.
Which is more profitable, Hansoh or Innovent?
Each figure as its report prints it, with its own period; a mark only where both cover the same kind of period.
Free cash flow
- HansohRMB 6.36 billion
- InnoventRMB 9.62 billion
Hansoh: 2025. Innovent: 2025.
Free cash flow yield
- Hansoh3.9 %
- Innovent7.3 %
Hansoh: Oct 18, 2026. Innovent: Oct 19, 2026.
Hansoh vs Innovent P/E: which stock costs more?
A lower P/E is a lower price per dollar of profit, not a better company, so these rows carry no mark.
Dividend yield
- Hansoh1.4 %
- Innovent0.0 %
Hansoh: Oct 18, 2026. Innovent: Oct 19, 2026.
P/E, last 12 months
- Hansoh24.6x
- Innovent111.6x
Hansoh: Oct 18, 2026. Innovent: Oct 19, 2026.
P/E, next 12 months
- Hansoh23.6x
- Innovent35.0x
Hansoh: Oct 18, 2026. Innovent: Oct 19, 2026.
Hansoh vs Innovent stock forecast: where could each be by October 2029?
- Hansoh base case HK$28.15 (−6 %) by October 2029, between HK$12.94 (bear) and HK$61.30 (bull); chances 25 % / 55 % / 20 %; weighted HK$30.98 (+2 %).
- Innovent base case HK$125.77 (+41 %) by October 2029, between HK$39.95 (bear) and HK$258.35 (bull); chances 35 % / 50 % / 15 %; weighted HK$115.62 (+30 %).
Each report builds its own three cases from the company's filings, as a return on its own price, dividends included. They are not an average of analysts' price targets, so they can differ from them.
Questions about Hansoh vs Innovent stock
Which pays a dividend, Hansoh or Innovent?
Hansoh does and Innovent does not: Hansoh's dividend yield was 1.4 % (Oct 18, 2026).
Why do these numbers differ from other sites?
Every figure here carries its own period and date, from each company's report. Other sites may use another period or a later price.
More on Hansoh and Innovent
Hansoh and Innovent pages
More head to head
This page compares the numbers. Each report gives the reasons.
New accounts get one company's ready report free. No card.New accounts get one company's ready report free. No card.
Information only, not investment advice. Each forecast gives three cases with their chances; it promises no price. Each price is that of the date shown; the two reports are of different dates.